首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of psychoactive drugs

缩写:

ISSN:0279-1072

e-ISSN:2159-9777

IF/分区:2.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引671
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kelan Thomas,Benjamin Malcolm,Dan Lastra Kelan Thomas
Recent research suggests that functional connectivity changes may be involved in the pathophysiology of psychiatric disorders. Hyperconnectivity in the default mode network has been associated with psychopathology, but psychedelic serotonin...
Kakia Nikolaou,Dorothea Kapoukranidou,Samuel Ndungu et al. Kakia Nikolaou et al.
Pre-clinical studies show that, following chronic opioid exposure, oxytocin neurons exhibit over-excitation upon withdrawal, causing an increase in oxytocin brain and plasma levels. Relevant clinical data on humans are scarce. This study in...
Matthew M Nour,Lisa Evans,Robin L Carhart-Harris Matthew M Nour
The psychedelic experience (including psychedelic-induced ego dissolution) can effect lasting change in a person's attitudes and beliefs. Here, we aimed to investigate the association between naturalistic psychedelic use and personality, po...
Maurizio Coppola,Raffaella Mondola Maurizio Coppola
Synthetic cannabinoid receptor agonists are a heterogeneous group of psychotropic drugs functionally related to Δ9-tetrahydrocannabinol. These substances, marketed as cannabis substitutes, have been associated with numerous cases of severe...
Cynthia I Campbell,Sujaya Parthasarathy,Kelly C Young-Wolff et al. Cynthia I Campbell et al.
The Affordable Care Act (ACA) was expected to benefit patients with substance use disorders, including opioid use disorders (OUDs). This study examined buprenorphine use and health services utilization by patients with OUDs pre- and post-AC...
Lydia Aletraris,Mary Bond Edmond,Paul M Roman Lydia Aletraris
This study measures the readiness of substance use disorder (SUD) treatment to use opportunities under the Affordable Care Act by examining Medicaid and private insurance acceptance between 2011 and 2013, as well as center characteristics a...
Khary K Rigg Khary K Rigg
Despite the growing popularity of MDMA (ecstasy/molly) among African Americans, their motives for using the drug are still largely unknown. The purpose of this study was to identify and describe the most salient motivations for using MDMA a...
Amity E Quinn,Maureen T Stewart,Mary Brolin et al. Amity E Quinn et al.
The Affordable Care Act (ACA) expanded insurance benefits and coverage for substance use disorder (SUD) treatment and encouraged delivery and payment reforms. Massachusetts passed a similar reform in 2006. This study aims to assess Massachu...
Sharon Reif,Timothy B Creedon,Constance M Horgan et al. Sharon Reif et al.
Opioid use disorders (OUDs) are receiving significant attention in the U.S. as a public health crisis. Access to treatment for OUDs is essential and was expected to improve following implementation of the federal parity law and the Affordab...
Lydia Aletraris,Paul M Roman,Jana Pruett Lydia Aletraris
This study examined patterns of medicalization in substance use disorder (SUD) that are aligned with the goals of the Affordable Care Act (ACA). Using a nationally representative sample of SUD treatment programs, we examined changes in seve...